Inphi Corporation (NYSE:IPHI) represented a move of 0.68 percent or $-0.36 per share and closed its previous day trading session at $25.15. 1.07 Million Shares were traded in the last trading session with an Average Volume of 901.16 Million Shares. The stock currently has a Market Capitalization of 1.1 Billion.
Inphi Corporation operates as a provider of fabless high-speed analog semiconductor solutions for the communications and computing markets. Its solutions provides interface between analog signals and digital information in high-performance systems such as telecommunications transport systems, enterprise networking equipment, datacenter and enterprise servers, storage platforms, test and measurement equipment and military systems. The Company’s products are designed into systems sold by OEMs, including Agilent Technologies, Inc., Alcatel-Lucent, Cisco Systems, Inc., Danaher Corporation, Dell Inc., EMC Corporation, Hewlett-Packard Company, Huawei, International Business Machines Corporation and Oracle Corporation. Inphi Corporation is headquartered in Santa Clara, California
The stock traded between $23.65 and $51.78 over 1-Year time period showing its price to sales ratio of 3.14. Inphi Corporation (NYSE:IPHI) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-28.04 and 200-Day Simple Moving Average of $-32.86. Its Price to Free Cash Flow is 23.6 and Price to Book of 2.63.
Analyst’s recommended the stock as 2.2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Inphi Corporation (NYSE:IPHI) reported its Actual EPS of $0.37/share. The analysts offering Earnings Estimates for the company were believing that Inphi Corporation could bring EPS of $0.35/share. The difference between Actual EPS and Estimated EPS was 0.02 Percent. Thus showing an Earnings Surprise of 5.7 Percent.
NewLink Genetics Corporation (NASDAQ:NLNK)
In the last trading session, NewLink Genetics Corporation (NASDAQ:NLNK) added its value by 3.2% closing at the price of $6.77. The stock currently has market capitalization of 272.56 Million, with average volume of 844.45 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently NewLink Genetics Corporation (NASDAQ:NLNK) is showing beta of 1.14. This particular value of beta suggests that NewLink Genetics Corporation (NASDAQ:NLNK) has historically moved 114% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for NewLink Genetics Corporation (NASDAQ:NLNK) is at $-2.44.
The stock currently has RSI of 34.52. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio also includes biologic and small-molecule immunotherapy products used for the treatment of oncology indications. NewLink Genetics Corporation is headquartered in Ames, Iowa.
NewLink Genetics Corporation (NASDAQ:NLNK) topped its 52-week high price of $25.17 on 04/03/17 and 52-Week Low Price of $ 5.90 on 06/12/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 11.26% and monthly volatility of 6.88% respectively.